These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37616532)

  • 41. Use of Methotrexate in the Treatment of Moderate to Severe Plaque Psoriasis in France: A Practice Survey.
    Fougerousse AC; Mery-Bossard L; Parier J; Taieb C; Bertolotti A; Maccari F;
    Clin Cosmet Investig Dermatol; 2021; 14():389-393. PubMed ID: 33935509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Guidelines on the use of methotrexate in psoriasis].
    Carretero G; Puig L; Dehesa L; Carrascosa JM; Ribera M; Sánchez-Regaña M; Daudén E; Vidal D; Alsina M; Muñoz-Santos C; López-Estebaranz JL; Notario J; Ferrandiz C; Vanaclocha F; García-Bustinduy M; Taberner R; Belinchón I; Sánchez-Carazo J; Moreno JC;
    Actas Dermosifiliogr; 2010 Sep; 101(7):600-13. PubMed ID: 20858386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methotrexate Management in Psoriasis: Are We Following the Guidelines?
    Lindqvist T; Salah LA; Gillstedt M; Wennberg AM; Osmancevic A
    Acta Derm Venereol; 2018 Apr; 98(4):449-451. PubMed ID: 29199349
    [No Abstract]   [Full Text] [Related]  

  • 44. Comment on: Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Boffa MJ; Smith A; Chalmers RJ
    Rheumatology (Oxford); 2009 Nov; 48(11):1464; author reply 1465. PubMed ID: 19671697
    [No Abstract]   [Full Text] [Related]  

  • 45. Reference interval for type III procollagen (PIIINP) using the Advia centaur PIIINP assay in adults and elderly.
    Pettersson-Pablo P; Samyn D; Wasim J; Vink M
    Scand J Clin Lab Invest; 2021 Dec; 81(8):649-652. PubMed ID: 34779323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolyl hydroxylase and procollagen III peptide levels in the sera from patients with collagen diseases and psoriasis.
    Sasaki T; Nakajima H
    J Dermatol; 1989 Jun; 16(3):207-11. PubMed ID: 2551942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liver biopsies and methotrexate: a time for reconsideration?
    Zachariae H
    J Am Acad Dermatol; 2000 Mar; 42(3):531-4. PubMed ID: 10688735
    [No Abstract]   [Full Text] [Related]  

  • 48. Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
    Iskandar IYK; Ashcroft DM; Warren RB; Evans I; McElhone K; Owen CM; Burden AD; Smith CH; Reynolds NJ; Griffiths CEM
    Br J Dermatol; 2017 May; 176(5):1297-1307. PubMed ID: 27589476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis.
    Maybury CM; Samarasekera E; Douiri A; Barker JN; Smith CH
    Br J Dermatol; 2014 Jun; 170(6):1237-47. PubMed ID: 24588075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A review of methotrexate-associated hepatotoxicity.
    Bath RK; Brar NK; Forouhar FA; Wu GY
    J Dig Dis; 2014 Oct; 15(10):517-24. PubMed ID: 25139707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of psoriasis with non-registered fumaric acid esters in The Netherlands: a nationwide survey among Dutch dermatologists.
    Fallah Arani S; Balak DM; Neumann HA; Kuipers MV; Thio HB
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):972-5. PubMed ID: 23822581
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differing patterns of methotrexate use for psoriatic disease among dermatologists and rheumatologists.
    Dupuis EC; Bhole VM; Dutz JP
    Br J Dermatol; 2012 Aug; 167(2):448-50. PubMed ID: 22309601
    [No Abstract]   [Full Text] [Related]  

  • 53. A comparison of four serum markers of fibrosis in the diagnosis of cirrhosis.
    Fabris C; Falleti E; Federico E; Toniutto P; Pirisi M
    Ann Clin Biochem; 1997 Mar; 34 ( Pt 2)():151-5. PubMed ID: 9133247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dermatologists' adherence to the guideline of the Dutch Society of Dermatology and Venereology with respect to the treatment with methotrexate for severe chronic plaque psoriasis: results from a Dutch survey.
    Berends MA; de Jong EM; van de Kerkhof PC; Gerritsen MJ
    Dermatology; 2007; 215(1):45-52. PubMed ID: 17587839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diagnostic values of type III Procollagen N-terminal peptide and combination assay of type III procollagen N-terminal peptide with CEA and CA 19-9 in gastric cancer].
    Akazawa S; Harada A; Futatsuki K
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1434-8. PubMed ID: 6588922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver fibrosis for the dermatologist: a review.
    Raahimi MM; Livesey A; Hamilton J; Shipman AR; Aspinall RJ
    Clin Exp Dermatol; 2023 Mar; 48(4):303-309. PubMed ID: 36763770
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methotrexate treatment for patients with psoriasis and risk of cutaneous melanoma: a nested case-control study.
    Polesie S; Gillstedt M; Paoli J; Osmancevic A
    Br J Dermatol; 2020 Oct; 183(4):684-691. PubMed ID: 31981364
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methotrexate and Adalimumab Decrease the Serum Levels of Cardiovascular Disease Biomarkers (VCAM-1 and E-Selectin) in Plaque Psoriasis.
    Zdanowska N; Owczarczyk-Saczonek A; Czerwińska J; Nowakowski JJ; Kozera-Żywczyk A; Owczarek W; Zdanowski W; Placek W
    Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32942670
    [No Abstract]   [Full Text] [Related]  

  • 59. Assessment of methotrexate hepatotoxicity in psoriasis patients: a prospective evaluation of four serum fibrosis markers.
    Chládek J; Simková M; Vanecková J; Hroch M; Vávrová J; Hůlek P
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1007-14. PubMed ID: 22882190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence-based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists.
    Paul C; Gallini A; Maza A; Montaudié H; Sbidian E; Aractingi S; Aubin F; Bachelez H; Cribier B; Joly P; Jullien D; Le Maître M; Misery L; Richard MA; Ortonne JP
    J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():2-11. PubMed ID: 21388453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.